SBFM

3.07% -0.0211

Dopo l'orario di chiusura: .62 -0.0465 -6.98%

Sunshine Biopharma Inc (SBFM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Sunshine Biopharma Inc

Healthcare (1064)

954-330-0684

333 LAS OLAS WAY, FORT LAUDERDALE

Prossima data di guadagno

Ultimi documenti SEC

SBFM's Discussions on Twitter

Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SBFM Sunshine Biopharma Inc	0.6665	3.27M	35.49M	-6.04M	-6.42M	-13.02
TAK Takeda Pharmaceutical Co Adr	17.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.53	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.80	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	69.69	29.36B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.70	20.39B	3.17B	1.29B	1.01B	27.09

Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie

Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari

Sunshine Biopharma Inc (SBFM)

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR

Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie

Shares traded below Nasdaq’s $1 minimum. Sunshine Biopharma (SBFM) has approved a possible reverse split. - Stock Titan

Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know - Eastern Progress

Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote & History - Yahoo! Finance Canada

SBFM Looks 59.3% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus

Sunshine Biopharma launches generic ondansetron in Canada - Investing.com

Sunshine Biopharma launches generic ondansetron in Canada By Investing.com - Investing.com Nigeria

Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Corsicana Daily Sun

A generic drug for nausea during cancer treatment launches in Canada - Stock Titan

Sunshine Biopharma Inc (SBFM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Sunshine Biopharma Stock (SUNB) Opinions on Coronavirus Drug Studies - Quiver Quantitative

Sunshine Biopharma Authorizes Reverse Stock Split of Up to 1-for-20 - Minichart

Sunshine Biopharma CEO Authorizes Potential Reverse Stock Split - TipRanks

SBFM Looks 51.6% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Weatherford Democrat

An oral drug candidate suppressed lung virus in infected mice - Stock Titan

EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies - Yahoo Finance

Sunshine Biopharma Adjusts Series B Warrant Exercise Price - TipRanks

Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com South Africa

Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com South Africa

Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 - Investing.com

Sunshine Biopharma (NASDAQ: SBFM) Anticipates $31M from Series B Warrant Exercises - kalkinemedia.com

Price to earnings forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView

Price to sales forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView

Sunshine Biopharma Inc. SEC Filing (Sep 9, 2026) - Stock Titan

Sunshine Biopharma Inc. (SBFM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Sunshine Biopharma Inc. (SBFM) Peer Comparison – Compare with Others - Value Research

Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com Nigeria

Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - kalkinemedia.com

SBFM Looks 52.9% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Cadillac News

Health Canada approves Atenolol, a drug used for high blood pressure and chest pain - Stock Titan

Sunshine Biopharma Inc. Warrant (SBFMW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Sunshine Biopharma (NASDAQ: SBFM) could raise $31M from warrants - Stock Titan

Dr. Andrew Keller to Leave Sunshine Biopharma Board at Term End - TradingView

Sunshine Biopharma Inc. Announces Term Completion of Dr. Andrew Keller as Director - marketscreener.com

Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer - The Batesville Daily Guard

Sunshine Biopharma Inc. Warrant (SBFMW) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sunshine (SBFMW) Market: Closes Nearly Flat at $0.05 in the Available Record; Levels: the Current Price Sits Inside the Supplied Technical RangeExhaustion Gap - vinanet.vn

Sunshine Biopharma wins Canadian approval for generic Enalapril tablets - Bitget

SBFM Looks 55.2% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus

BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril - Bitget

Sunshine Biopharma receives Canadian approval for generic enalapril By Investing.com - Investing.com Canada

Sunshine Biopharma receives Canadian approval for generic enalapril - Investing.com

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Eagle-Tribune

EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug - Yahoo Finance

Sunshine (SBFM) Quarterly Performance Check: The Company Lists Its Latest Available Figures in the Reported Period; Session Reaction: The Stock Ends Up 1.79% in the Latest ReadingEarnings Momentum Score - vinanet.vn

101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com

Sunshine Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com

Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SBFM